BioProcess Technology Consultants Appoints Lars Skriver as Senior Consultant and Expands European Services
BioProcess Technology Consultants, a world leader in biopharmaceutical technical, strategic, and CMC (Chemistry, Manufacturing, and Controls) consulting, has opened a European office in Denmark and appointed Lars Skriver, Ph.D., Senior Consultant, to lead its operations.
The European office will continue to deliver the company’s full range of services for the development and commercialization of biopharmaceutical products to the growing international market of biopharmaceutical and biotechnology companies. Since its inception, BioProcess Technology Consultants has served over 400 clients across the globe from its Boston area headquarters, which recently moved to Woburn, Massachusetts.
“The addition of Lars to our team and the establishment of this new European office confirm the strength of our international commitment,” said Howard L. Levine, Ph.D., President of BioProcess Technology Consultants. “It will provide our European clients with more responsive and economical services through a prominent local biopharmaceutical expert along with continued access to the full breadth and scope of our services. We are delighted to have Lars join us as a key addition to our team.”
Before his appointment as Senior Consultant at BioProcess Technology Consultants, Dr. Skriver was Director and Principal Consultant at L&K Biosciences, a company he co-founded. For the past two years, Dr. Skriver and BioProcess Technology Consultants have worked closely together through the company’s strategic alliance with L&K Biosciences. Dr. Skriver now joins BioProcess Technology Consultants to further expand the company’s ability to provide clients with custom-tailored services that support product discovery and development from clone to commercial® and span all phases of the product lifecycle.
Prior to founding L&K Biosciences, Dr. Skriver was Operational Manager in Protein Technology and Process Development at Novo Nordisk, Denmark where he was involved in the development of a number of recombinant human protein products. Dr. Skriver also co-founded SMC Biotech ApS, Denmark and CellRx Ltd., Cambridge UK (CSO), and has served on Scientific Advisory Boards at Dyax Corporation, Alphalyse A/S and at Rutgers University, NJ Biotechnology Drug Development. He holds a Ph.D. in Biochemistry from the University of Copenhagen.
About BioProcess Technology Consultants, Inc.
Founded in 1994, BioProcess Technology Consultants is the recognized worldwide leader in biologics CMC consulting, providing a full range of technical, regulatory, and strategic assistance to biopharmaceutical and biotechnology companies in the development and commercialization of biopharmaceutical products. The company specializes in helping develop manufacturing processes and strategies and assists in developing product discovery and process development programs to speed products from clone to commercial® and enhance the overall value of client companies. BioProcess Technology Consultants also helps investors make informed decisions by providing technical and business evaluations of new products and technologies and product discovery, development, and commercialization plans of potential investments and existing portfolio companies. For more about BioProcess Technology Consultants, visit https://www.bptc.com.